Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin
Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin
复制标题
DOI:
10.1136/ard.59.3.217
复制
发表时间:
2000-03-01
影响因子:
27.4
通讯作者:
Moutsopoulos, HM
中科院分区:
文献类型:
--
作者:
Voulgarelis, M;Kokori, SIG;Moutsopoulos, HM
Objective-To study the prevalence of different causes of anaemia in patients with systemic lupus erythematosus (SLE) and their associations with immunological and clinical parameters and to evaluate the contribution of erythropoietin (Epo) and anti-erythropoietin (anti-Epo) autoantibodies to the development of SLE anaemia.Methods-132 SLE patients with anaemia (defined as haemoglobin of 12 g/dl or less for women and 13.5 g/dl or less for men) from among a total of 345 consecutive SLE patients were prospectively enrolled into the study. Standard haematological and immunological tests were performed and serum Epo and anti-Epo antibodies were assayed.Results-The identified causes were anaemia of chronic disease (ACD) n=49 (37.1%), iron deficiency anaemia (IDA) n=47 (35.6%), autoimmune haemolytic anaemia (AHA) n=19 (14.4%) and other causes n=17 (12.9%). There was significant heterogeneity in the severity of anaemia between the four groups (p